Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ANGEL-MeVO-TNK: Intra-arterial Tenecteplase for Acute Medium Vessel Occlusion Stroke
NCT07357987Phase 3Recruiting
- Sponsor
- Beijing Tiantan Hospital
- Start
- Jan 2026
- Primary completion
- Sep 2027
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of tenecteplase in ischemic stroke, sponsored by Beijing Tiantan Hospital. Started Jan 2026; status: recruiting.
02
Drugs
tenecteplase
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on NCT07357987.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07357987.